Related Experiment Video
Updated: Aug 23, 2026

Evaluating Vascular Hyperpermeability-inducing Agents in the Skin with the Miles Assay
Published on: June 19, 2018
Tissue expression of 165-aa vascular permeability factor after spinal cord injury is not influenced by dexamethasone
Jesús Vaquero1, Mercedes Zurita
1Department of Surgery, Neuroscience Research Unit of the Mapfre-Medicine Foundation, Neurosurgical Service, Puerta de Hierro Hospital, Autonomous University, San Martín de Porres 4, 28035 Madrid, Spain. jvaqueroc@telefonica.net
Abstract:
Using immunohistochemistry, RT-PCR, and Western Blot techniques, we studied the tissue expression of the 165-aa Vascular permeability factor (VPF) after spinal cord injury (SCI) in adult Wistar rats. The results were compared according to that the animals received or non-dexamethasone, at the dose of 1mg/kg and day after trauma. Furthermore, the different functional recovery between treated and non-treated animals was recorded. Although the administration of dexamethasone showed a beneficial effect on the functional recovery of the animals, the tissue expression of VPF after SCI is not influenced by dexamethasone administration. Therefore, the neuroprotective effect of the dexamethasone after experimental SCI is not mediated through an interference on the biological effects of the 165-aa vascular permeability factor.
More Related Videos
Related Concept Videos
Acute Inflammation III: Local and Systemic Effects
Vascular Spasm

